Treatment Indications: correction of fine lines and superficial wrinkles (periorbital, lip augmentation and contouring; nasolabial folds;, tear trough correction;, facial bio‑reinforcement and mild volumetric restoration;, skin hydration and turgor improvement
Release form: 1 × 1.1 mL pre‑filled sterile glass syringe
Indications: superficial to mid‑dermal injection for smoothing fine lines, superficial wrinkles, and gentle volumetric restoration;, monophasic gel utilizing BDDE cross‑linking technology with low‑temperature processing for smooth injection, even tissue integration, and natural distribution;, residual BDDE not detected;, providing subtle correction with minimal migration (effect duration ~9–12 months)